Jazz Pharmaceuticals Appoints Philip Johnson As Chief Financial Officer
Feb 21, 2024•almost 2 years ago
Position
Vice President
Company
Jazz Pharmaceuticals
Description
Jazz Pharmaceuticals plc announces the appointment of Philip Johnson as Executive Vice President and Chief Financial Officer, effective March 1, 2024.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months